Organon Acquired by Sun Pharma | Healthcare M&A Deal

Sun Pharma has agreed to acquire Organon, a pharmacy business in New Jersey, for $11.75B. Sun Pharma acquisitions in healthcare M&A focus on expanding branded and specialty medicines, while Organon develops women’s health and other therapeutic products. The Sun Pharma acquisition of Organon supports a strategic acquisition strategy to strengthen product pipelines and commercial reach in the pharmacy sector. This merger acquisition is a strategic acquisition by a strategic buyer, valued at $14 per share, and is expected to close after regulatory approvals under announced terms.